Top compounds associated with response to ELN


Feature Type Standardized
Nominal ANOVA
mRNA Dasatinib CTRPv2 pan-cancer AAC 0.048 0.2
mRNA BX-795 GDSC1000 pan-cancer AAC 0.045 0.2
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.043 0.2
mRNA PF-750 CTRPv2 pan-cancer AAC -0.05 0.2
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC -0.045 0.2
mRNA BRD-K03911514 CTRPv2 pan-cancer AAC 0.073 0.2
mRNA Sunitinib FIMM pan-cancer AAC -0.24 0.2
mRNA thapsigargin gCSI pan-cancer AAC -0.077 0.2
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.046 0.2
mRNA Erlotinib CCLE pan-cancer AAC -0.059 0.2
Download CSV